{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:41:29Z","timestamp":1792802489891,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.toxlet.2013.06.241","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T12:31:31Z","timestamp":1373286691000},"page":"23-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer"],"prefix":"10.1016","volume":"222","author":[{"given":"Guo-Qing","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Peng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2013.06.241_bib0005","article-title":"Deregulation of PI3K\/Akt\/mTOR signaling pathways by isoflavones and its implication in cancer treatment","author":"Ahmad","year":"2012","journal-title":"Anticancer Agents in Medical Chemistry"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/cr.2008.18","article-title":"STAT3 as a target for inducing apoptosis in solid and hematological tumors","volume":"18","author":"Al Zaid Siddiquee","year":"2008","journal-title":"Cell Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0015","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1158\/0008-5472.CAN-08-4235","article-title":"Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer","volume":"69","author":"Banerjee","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0020","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","article-title":"Pancreatic cancer biology and genetics","volume":"2","author":"Bardeesy","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0025","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/1947601910383416","article-title":"Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth","volume":"1","author":"Chun","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0035","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0040","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0045","doi-asserted-by":"crossref","first-page":"e58055","DOI":"10.1371\/journal.pone.0058055","article-title":"Cytotoxic Activity and Apoptosis-Inducing Potential of Di-spiropyrrolidino and Di-spiropyrrolizidino Oxindole Andrographolide Derivatives","volume":"8","author":"Dey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0050","first-page":"114","article-title":"Src in cancer: deregulation and consequences for cell behaviour","volume":"1602","author":"Frame","year":"2002","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12094-007-0138-9","article-title":"Natural products as leads to anticancer drugs","volume":"9","author":"Gordaliza","year":"2007","journal-title":"Clinical and Translational Oncology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0060","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3109\/10428194.2011.555891","article-title":"The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma","volume":"52","author":"Gunn","year":"2011","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1124\/jpet.104.072512","article-title":"Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse","volume":"312","author":"Iruretagoyena","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjp.2008.368","article-title":"Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis","volume":"155","author":"Jada","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0075","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1158\/1078-0432.CCR-10-3284","article-title":"Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis","volume":"17","author":"Jamieson","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/mc.20741","article-title":"Critical roles of cellular glutathione homeostasis and jnk activation in andrographolide-mediated apoptotic cell death in human hepatoma cells","volume":"50","author":"Ji","year":"2011","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0085","first-page":"2439","article-title":"Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression","volume":"27","author":"Jiang","year":"2007","journal-title":"Anticancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0090","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jss.2012.05.065","article-title":"Akt\/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells","volume":"178","author":"Kagawa","year":"2012","journal-title":"Journal of Surgical Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/156652412802480826","article-title":"Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase\/Akt signaling pathway","volume":"12","author":"Kumar","year":"2012","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2407-5-127","article-title":"Survivin expression and its clinical significance in pancreatic cancer","volume":"5","author":"Lee","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2010.01.009","article-title":"Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K\/Akt signaling pathway","volume":"632","author":"Lee","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2007.04.027","article-title":"Andrographolide induces cell cycle arrest at G2\/M phase and cell death in HepG2 cells via alteration of reactive oxygen species","volume":"568","author":"Li","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.lfs.2012.04.044","article-title":"Inactivation of PI3K\/Akt signaling mediates proliferation inhibition and G2\/M phase arrest induced by andrographolide in human glioblastoma cells","volume":"90","author":"Li","year":"2012","journal-title":"Life Science"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1681.2011.05633.x","article-title":"Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer","volume":"39","author":"Lim","year":"2012","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.taap.2010.11.014","article-title":"Andrographolide down-regulates hypoxia-inducible factor-1alpha in human non-small cell lung cancer A549 cells","volume":"250","author":"Lin","year":"2011","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0135","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-09-2468","article-title":"Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc723","article-title":"Natural products in cancer chemotherapy: past, present and future","volume":"2","author":"Mann","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0145","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1078-0432.CCR-10-1670","article-title":"Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth","volume":"17","author":"Nagaraj","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0160","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/SLA.0b013e3182827a65","article-title":"Immunohistochemically detected expression of 3 major genes (CDKN2A\/p16, TP53, and SMAD4\/DPC4) strongly predicts survival in patients with resectable pancreatic cancer","volume":"258","author":"Oshima","year":"2013","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0016-5085(03)01064-3","article-title":"Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer","volume":"125","author":"Scholz","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.intimp.2006.10.002","article-title":"Antiangiogenic activity of Andrographis paniculata extract and andrographolide","volume":"7","author":"Sheeja","year":"2007","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/08923970701282726","article-title":"Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide","volume":"29","author":"Sheeja","year":"2007","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.bjp.0704493","article-title":"Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect","volume":"135","author":"Shen","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cbi.2009.04.011","article-title":"Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression","volume":"180","author":"Shi","year":"2009","journal-title":"Chemico Biological Interactions"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cbi.2008.06.006","article-title":"Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide","volume":"174","author":"Shi","year":"2008","journal-title":"Chemico Biological Interactions"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA: A Cancer Journal of Clinicians"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ijc.24424","article-title":"Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma","volume":"125","author":"Simon","year":"2009","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0205","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/sj.onc.1208470","article-title":"Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity","volume":"24","author":"Sun","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0210","first-page":"1796","article-title":"Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias","volume":"6","author":"Tamm","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0215","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1476-5381.2009.00627.x","article-title":"Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells","volume":"159","author":"Tan","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0220","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-09-0536","article-title":"Cucurbitacin B induces apoptosis by inhibition of the JAK\/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells","volume":"69","author":"Thoennissen","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1534735407305985","article-title":"Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury","volume":"6","author":"Trivedi","year":"2007","journal-title":"Integrative Cancer Therapies"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0230","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","article-title":"Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo","volume":"293","author":"Wang","year":"2010","journal-title":"Cancer Letters"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0240","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00432-012-1152-z","article-title":"Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in pancreatic cancer both in vitro and in vivo","volume":"138","author":"Wang","year":"2012","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0245","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/CCO.0b013e32835b639e","article-title":"p21WAF1 and tumourigenesis: 20 years after","volume":"25","author":"Warfel","year":"2013","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0250","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2008.11.015","article-title":"Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells","volume":"276","author":"Yang","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0255","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1158\/1078-0432.CCR-10-0883","article-title":"Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata","volume":"16","author":"Yang","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0260","first-page":"1557","article-title":"Regulation of p21WAF1\/CIP1 expression by p53-independent pathways","volume":"12","author":"Zeng","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0265","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.bcp.2009.12.014","article-title":"Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin","volume":"79","author":"Zhou","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.toxlet.2013.06.241_bib0270","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcp.2006.04.019","article-title":"Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells","volume":"72","author":"Zhou","year":"2006","journal-title":"Biochemical Pharmacology"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427413011223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427413011223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T12:25:42Z","timestamp":1563366342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427413011223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0378427413011223"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2013.06.241","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2013.06.241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}